← IDEXX LABORATORIES INC /DE
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.8b | $2.0b | $2.2b | $2.4b | $2.7b | $3.2b | $3.4b | $3.7b | $3.9b | $4.3b | |
| Cost of Revenue | $800.0m | $871.7m | $971.7m | $1.0b | $1.1b | $1.3b | $1.4b | $1.5b | $1.5b | $1.6b | |
| Gross Profit | $975.4m | $1.1b | $1.2b | $1.4b | $1.6b | $1.9b | $2.0b | $2.2b | $2.4b | $2.7b | |
| Operating Expenses | — | — | $750.2m | — | — | — | — | — | $1.3b | $1.3b | |
| Operating Income (Loss) | $350.2m | $413.0m | $491.3m | $552.8m | $694.5m | $932.0m | $898.8m | $1.1b | $1.1b | $1.4b | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $9.5m | $9.0m | $8.9m | $9.4m | $9.8m | $12.1m | $15.0m | $13.8m | $17.1m | $20.2m | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($1.3m) | $1.1m | ($3.1m) | ($1.1m) | $600k | ($2.1m) | ($3.4m) | ($1.1m) | ($4.5m) | ($4.2m) | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $227.9m | $268.7m | $337.4m | $378.0m | $483.7m | $690.0m | $684.7m | $889.1m | $897.3m | $1.1b | |
| Interest and Other Income | $3.7m | $5.3m | $1.2m | $427k | $586k | $434k | $1.1m | $5.6m | $12.7m | $3.0m | |
| Lease Income | — | — | — | $20.8m | $17.5m | $20.8m | $20.3m | $20.7m | $13.9m | $15.8m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | — | — | $902.7m | $860.0m | $1.1b | $1.1b | $1.3b | |
| Net Income (Loss) Attributable to Parent | $222.0m | $263.1m | $377.0m | $427.7m | $581.8m | $744.8m | $679.1m | $845.0m | $887.9m | $1.1b | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $9k | $125k | $16k | $72k | $355k | ($1k) | $0 | $0 | — | — | |
| Earnings Per Share, Basic | $2.47 | $3.00 | $4.34 | $4.97 | $6.82 | $8.74 | $8.12 | $10.17 | $10.77 | $13.17 | |
| Earnings Per Share, Diluted | $2.44 | $2.94 | $4.26 | $4.89 | $6.71 | $8.60 | $8.03 | $10.06 | $10.67 | $13.08 | |
| Weighted Average Number of Shares Outstanding, Basic | 89.7m | 87.8m | 86.9m | 86.1m | 85.3m | 85.2m | 83.6m | 83.1m | 82.5m | 80.4m | |
| Weighted Average Number of Shares Outstanding, Diluted | 90.9m | 89.6m | 88.5m | 87.5m | 86.7m | 86.6m | 84.6m | 84.0m | 83.2m | 81.0m | |
| Research and Development Expense | $101.1m | $109.2m | $117.9m | $133.2m | $141.2m | $161.0m | $254.8m | $191.0m | $219.8m | $251.2m | |
| General and Administrative Expense | $207.0m | $220.9m | $244.9m | $261.3m | $300.8m | $309.7m | $326.2m | $335.8m | $442.3m | $404.8m | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $31.2m | $38.9m | |
| Current Income Tax Expense (Benefit) | — | — | $79.6m | $88.4m | $116.6m | $161.2m | $215.8m | $264.4m | $246.2m | $133.5m | |
| Interest Expense | $32.0m | $37.2m | $34.7m | $31.1m | $33.1m | $29.8m | $39.9m | $41.6m | — | — | |
| Operating Lease, Expense | — | — | — | $21.1m | $21.7m | $23.0m | $26.8m | $29.1m | $32.4m | $36.3m | |
| Selling and Marketing Expense | $317.1m | $354.3m | $387.4m | $418.2m | $434.4m | $486.7m | $524.5m | $566.1m | $588.5m | $643.5m | |
| Income Tax Expense (Benefit) | $99.8m | $117.8m | $80.7m | $94.4m | $79.9m | $157.8m | $180.9m | $216.1m | $222.0m | $264.7m | |
| Interest Income (Expense), Nonoperating, Net | ($28.4m) | ($32.0m) | ($33.6m) | ($30.6m) | ($32.5m) | ($29.4m) | ($38.8m) | ($36.0m) | — | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.